My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 97

    1.

    A robust classifier of high predictive value to identify good prognosis patients in ER-negative breast cancer.

    Teschendorff AE, Caldas C.

    Breast Cancer Res. 2008;10(4):R73. Epub 2008 Aug 28.

    PMID:
    18755024
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    2.

    Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.

    Pentheroudakis G, Kalogeras KT, Wirtz RM, Grimani I, Zografos G, Gogas H, Stropp U, Pectasides D, Skarlos D, Hennig G, Samantas E, Bafaloukos D, Papakostas P, Kalofonos HP, Pavlidis N, Fountzilas G.

    Breast Cancer Res Treat. 2009 Jul;116(1):131-43. Epub 2008 Jul 31.

    PMID:
    18668363
    [PubMed - indexed for MEDLINE]

    Related citations

    3.

    Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.

    Paik S, Tang G, Shak S, Kim C, Baker J, Kim W, Cronin M, Baehner FL, Watson D, Bryant J, Costantino JP, Geyer CE Jr, Wickerham DL, Wolmark N.

    J Clin Oncol. 2006 Aug 10;24(23):3726-34. Epub 2006 May 23.

    PMID:
    16720680
    [PubMed - indexed for MEDLINE]

    Related citations

    4.

    High expression of two genes selected by iAFLP: a new prognostic factor of estrogen receptor-positive breast cancer.

    Aritake N, Tamaki Y, Masuda N, Nakano Y, Monden T, Noguchi S, Monden M.

    Oncol Rep. 2004 Aug;12(2):381-7.

    PMID:
    15254706
    [PubMed - indexed for MEDLINE]

    Related citations

    5.

    Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen.

    Habashy HO, Powe DG, Staka CM, Rakha EA, Ball G, Green AR, Aleskandarany M, Paish EC, Douglas Macmillan R, Nicholson RI, Ellis IO, Gee JM.

    Breast Cancer Res Treat. 2010 Jan;119(2):283-93. Epub 2009 Feb 24.

    PMID:
    19238537
    [PubMed - indexed for MEDLINE]

    Related citations

    6.

    Expression profiling to predict postoperative prognosis for estrogen receptor-negative breast cancers by analysis of 25,344 genes on a cDNA microarray.

    Nagahata T, Onda M, Emi M, Nagai H, Tsumagari K, Fujimoto T, Hirano A, Sato T, Nishikawa K, Akiyama F, Sakamoto G, Kasumi F, Miki Y, Tanaka T, Tsunoda T.

    Cancer Sci. 2004 Mar;95(3):218-25.

    PMID:
    15016320
    [PubMed - indexed for MEDLINE]

    Related citations

    7.

    Expression pattern of stromal cell-derived factor-1 chemokine in invasive breast cancer is correlated with estrogen receptor status and patient prognosis.

    Kobayashi T, Tsuda H, Moriya T, Yamasaki T, Kikuchi R, Ueda S, Omata J, Yamamoto J, Matsubara O.

    Breast Cancer Res Treat. 2010 Oct;123(3):733-45. Epub 2009 Dec 18.

    PMID:
    20020198
    [PubMed - indexed for MEDLINE]

    Related citations

    8.

    Impact of triple negative phenotype on breast cancer prognosis.

    Kaplan HG, Malmgren JA.

    Breast J. 2008 Sep-Oct;14(5):456-63. Epub 2008 Jul 24.

    PMID:
    18657139
    [PubMed - indexed for MEDLINE]

    Related citations

    9.

    Estrogen receptor-related genes as an important panel of predictors for breast cancer response to neoadjuvant chemotherapy.

    Chen Y, Chen C, Yang B, Xu Q, Wu F, Liu F, Ye X, Meng X, Mougin B, Liu G, Shen Z, Shao Z, Wu J.

    Cancer Lett. 2011 Mar 1;302(1):63-8. Epub 2011 Jan 8.

    PMID:
    21220187
    [PubMed - indexed for MEDLINE]

    Related citations

    10.

    Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status.

    Dowsett M, Houghton J, Iden C, Salter J, Farndon J, A'Hern R, Sainsbury R, Baum M.

    Ann Oncol. 2006 May;17(5):818-26. Epub 2006 Feb 23.

    PMID:
    16497822
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    11.

    Genes responsive to both oxidant stress and loss of estrogen receptor function identify a poor prognosis group of estrogen receptor positive primary breast cancers.

    Yau C, Benz CC.

    Breast Cancer Res. 2008;10(4):R61. Epub 2008 Jul 17.

    PMID:
    18631401
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    12.

    Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients.

    Liu S, Chia SK, Mehl E, Leung S, Rajput A, Cheang MC, Nielsen TO.

    Breast Cancer Res Treat. 2010 Jan;119(1):53-61. Epub 2009 Feb 10.

    PMID:
    19205877
    [PubMed - indexed for MEDLINE]

    Related citations

    13.

    How ADAM-9 and ADAM-11 differentially from estrogen receptor predict response to tamoxifen treatment in patients with recurrent breast cancer: a retrospective study.

    Sieuwerts AM, Meijer-van Gelder ME, Timmermans M, Trapman AM, Garcia RR, Arnold M, Goedheer AJ, Portengen H, Klijn JG, Foekens JA.

    Clin Cancer Res. 2005 Oct 15;11(20):7311-21.

    PMID:
    16243802
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    14.

    Urokinase-type plasminogen activator and its inhibitor PAI-1: predictors of poor response to tamoxifen therapy in recurrent breast cancer.

    Foekens JA, Look MP, Peters HA, van Putten WL, Portengen H, Klijn JG.

    J Natl Cancer Inst. 1995 May 17;87(10):751-6.

    PMID:
    7563153
    [PubMed - indexed for MEDLINE]

    Related citations

    15.

    Expression patterns and prognostic value of Bag-1 and Bcl-2 in breast cancer.

    Nadler Y, Camp RL, Giltnane JM, Moeder C, Rimm DL, Kluger HM, Kluger Y.

    Breast Cancer Res. 2008;10(2):R35. Epub 2008 Apr 23.

    PMID:
    18430249
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    16.

    Determination of estrogen receptors in paraffin-embedded tissue. Techniques and the value in breast cancer treatment.

    Andersen J.

    Acta Oncol. 1992;31(6):611-27. Review.

    PMID:
    1281648
    [PubMed - indexed for MEDLINE]

    Related citations

    17.

    Low expression of a few genes indicates good prognosis in estrogen receptor positive breast cancer.

    Buechler S.

    BMC Cancer. 2009 Jul 20;9:243.

    PMID:
    19619298
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    18.

    Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98.

    Viale G, Regan MM, Maiorano E, Mastropasqua MG, Dell'Orto P, Rasmussen BB, Raffoul J, Neven P, Orosz Z, Braye S, Ohlschlegel C, Thürlimann B, Gelber RD, Castiglione-Gertsch M, Price KN, Goldhirsch A, Gusterson BA, Coates AS.

    J Clin Oncol. 2007 Sep 1;25(25):3846-52. Epub 2007 Aug 6.

    PMID:
    17679725
    [PubMed - indexed for MEDLINE]

    Related citations

    19.

    Expression of c-erbB2, cyclin D1 and estrogen receptor and their clinical implications in the invasive ductal carcinoma of the breast.

    Lee A, Park WC, Yim HW, Lee MA, Park G, Lee KY.

    Jpn J Clin Oncol. 2007 Sep;37(9):708-14.

    PMID:
    17940078
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    20.

    Expression of Com-1/P8 in human breast cancer and its relevance to clinical outcome and ER status.

    Jiang WG, Watkins G, Douglas-Jones A, Mokbel K, Mansel RE, Fodstad O.

    Int J Cancer. 2005 Dec 10;117(5):730-7.

    PMID:
    15957166
    [PubMed - indexed for MEDLINE]

    Related citations

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Filter your results:

      Find related data

      Recent activity

      You are here: NCBI > Literature > PubMed
      Write to the Help Desk